These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30427558)

  • 21. The prolyl hydroxylase OGFOD1 promotes cancer cell proliferation by regulating the expression of cell cycle regulators.
    Fujisaki T; Saito K; Kikuchi T; Kondo E
    FEBS Lett; 2023 Apr; 597(8):1073-1085. PubMed ID: 36464654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2.
    Abboud MI; McAllister TE; Leung IKH; Chowdhury R; Jorgensen C; Domene C; Mecinović J; Lippl K; Hancock RL; Hopkinson RJ; Kawamura A; Claridge TDW; Schofield CJ
    Chem Commun (Camb); 2018 Mar; 54(25):3130-3133. PubMed ID: 29522057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection.
    Requena-Ibáñez JA; Santos-Gallego CG; Rodriguez-Cordero A; Zafar MU; Badimon JJ
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1187-1196. PubMed ID: 34533692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deleting the ribosomal prolyl hydroxylase OGFOD1 protects mice against diet-induced obesity and insulin resistance.
    Rodriguez R; Harris M; Kennedy LM
    PLoS One; 2024; 19(6):e0304761. PubMed ID: 38843265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light.
    Li Z; Su K; Jiang Z; Yu Y; You Q; Zhang X
    J Med Chem; 2019 Aug; 62(16):7583-7588. PubMed ID: 31244107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of prolyl hydroxylase 2 inhibitors based on quantitative strategy of peptides.
    Zhang Y; Nsanzamahoro S; Wang CB; Wang WF; Yang JL
    J Chromatogr A; 2022 Aug; 1679():463411. PubMed ID: 35973337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors.
    Wu Y; Jiang Z; You Q; Zhang X
    Bioorg Med Chem; 2017 Aug; 25(15):3891-3899. PubMed ID: 28625716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of prolyl hydroxylase 2 inhibitors with new chemical scaffolds as in vivo active erythropoietin inducers through a combined virtual screening strategy.
    Yu Z; Li Z; Yu Q; Wang Z; Song H; Sun H; Fan R; Bi A; Zhang J; Zhang X
    Chem Biol Drug Des; 2020 Feb; 95(2):270-278. PubMed ID: 31628888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration.
    Fan L; Li J; Yu Z; Dang X; Wang K
    Biomed Res Int; 2014; 2014():239356. PubMed ID: 24895555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth.
    Katz MJ; Acevedo JM; Loenarz C; Galagovsky D; Liu-Yi P; Pérez-Pepe M; Thalhammer A; Sekirnik R; Ge W; Melani M; Thomas MG; Simonetta S; Boccaccio GL; Schofield CJ; Cockman ME; Ratcliffe PJ; Wappner P
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4025-30. PubMed ID: 24550463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
    Riopel M; Moon JS; Bandyopadhyay GK; You S; Lam K; Liu X; Kisseleva T; Brenner D; Lee YS
    Mol Metab; 2020 Nov; 41():101039. PubMed ID: 32534258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preconditioning of Cardiosphere-Derived Cells With Hypoxia or Prolyl-4-Hydroxylase Inhibitors Increases Stemness and Decreases Reliance on Oxidative Metabolism.
    Tan SC; Gomes RS; Yeoh KK; Perbellini F; Malandraki-Miller S; Ambrose L; Heather LC; Faggian G; Schofield CJ; Davies KE; Clarke K; Carr CA
    Cell Transplant; 2016; 25(1):35-53. PubMed ID: 25751158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate.
    Majamaa K; Turpeenniemi-Hujanen TM; Latipää P; Günzler V; Hanauske-Abel HM; Hassinen IE; Kivirikko KI
    Biochem J; 1985 Jul; 229(1):127-33. PubMed ID: 2994628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.
    Loenarz C; Sekirnik R; Thalhammer A; Ge W; Spivakovsky E; Mackeen MM; McDonough MA; Cockman ME; Kessler BM; Ratcliffe PJ; Wolf A; Schofield CJ
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4019-24. PubMed ID: 24550462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collagen Prolyl 4-Hydroxylase as a Therapeutic Target.
    Vasta JD; Raines RT
    J Med Chem; 2018 Dec; 61(23):10403-10411. PubMed ID: 29986141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis.
    Bakshi HA; Mishra V; Satija S; Mehta M; Hakkim FL; Kesharwani P; Dua K; Chellappan DK; Charbe NB; Shrivastava G; Rajeshkumar S; Aljabali AA; Al-Trad B; Pabreja K; Tambuwala MM
    Inflammation; 2019 Dec; 42(6):2032-2036. PubMed ID: 31377947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.
    Keely S; Campbell EL; Baird AW; Hansbro PM; Shalwitz RA; Kotsakis A; McNamee EN; Eltzschig HK; Kominsky DJ; Colgan SP
    Mucosal Immunol; 2014 Jan; 7(1):114-23. PubMed ID: 23695513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation.
    Byts N; Sharma S; Malm T; Kaakinen M; Korhonen P; Jaakkonen L; Keuters M; Huuskonen M; Pietilä I; Koistinaho J; Koivunen P; Myllyharju J
    J Biol Chem; 2022 Mar; 298(3):101721. PubMed ID: 35151685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes.
    Stoehr A; Yang Y; Patel S; Evangelista AM; Aponte A; Wang G; Liu P; Boylston J; Kloner PH; Lin Y; Gucek M; Zhu J; Murphy E
    Cardiovasc Res; 2016 Jun; 110(3):346-58. PubMed ID: 27095734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of firefly luciferase activity by a HIF prolyl hydroxylase inhibitor.
    Günter J; Wenger RH; Scholz CC
    J Photochem Photobiol B; 2020 Sep; 210():111980. PubMed ID: 32745950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.